Fgf2 induces resistance to nilotinib through mapk pathway activation in kit mutated melanoma

MLA

Tétu, Pauline, et al. “Fgf2 Induces Resistance to Nilotinib through Mapk Pathway Activation in Kit Mutated Melanoma.” Cancers (Basel), 12 (5, 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1192457450&authtype=sso&custid=ns315887.

APA

Tétu, P., Delyon, J., André, J., De Moura, C. R., Sabbah, M., Ghanem, G. E., Batistella, M., Mourah, S., Lebbe, C., & Dumaz, N. (2020). Fgf2 induces resistance to nilotinib through mapk pathway activation in kit mutated melanoma. Cancers (Basel), 12 (5.

Chicago

Tétu, Pauline, Julie Delyon, Jocelyne André, Coralie Reger De Moura, Malak Sabbah, Ghanem Elias Ghanem, Maxime Batistella, Samia Mourah, Céleste Lebbe, and Nicolas Dumaz. 2020. “Fgf2 Induces Resistance to Nilotinib through Mapk Pathway Activation in Kit Mutated Melanoma.” Cancers (Basel), 12 (5. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1192457450&authtype=sso&custid=ns315887.